StonvexLoading…
StonvexStonvexStonvexCore line items from NRC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $137.39M | $143.06M | $148.58M | $151.57M |
Operating Income | $22.59M | $35.19M | $40.05M | $46.54M |
Net Income | $11.60M | $24.78M | $30.97M | $31.80M |
EPS (Diluted) | $50.00 | $1.04 | $1.25 | $1.27 |
Total Assets | $134.88M | $132.54M | $122.44M | $130.46M |
Total Liabilities | $120.89M | $101.25M | $73.48M | $58.43M |
Cash & Equivalents | $4.14M | $4.23M | $6.65M | $25.03M |
Free Cash Flow OCF − CapEx | $15.74M | $19.18M | $22.33M | $26.43M |
Shares Outstanding | 22.64M | 23.08M | 24.22M | 24.63M |